Monday, September 27, 2021
Home Tags Vaccines

Vaccines Related News

COVID-19 vaccine

Trial begins for world-first multivariant COVID-19 vaccine booster

A phase one trial for the world’s first multivariant COVID-19 booster vaccine has been launched in Manchester. Initiated by pharmaceutical company Gritstone, in partnership with...
B lymphocytes

Enhancing vaccine design with B lymphocytes discovery

Findings from a research study of B lymphocytes – otherwise known as B cells – may aid in advancing the design of future vaccines. The...
new COVID vaccine

Defence Therapeutics’ new COVID vaccine achieves successful testing

Biotechnology experts Defence Therapeutics have sensationally announced that their new COVID vaccine has demonstrated effectiveness in a non-rodent model. The new COVID vaccine – called...
COVID-19 booster vaccines

Health experts believe COVID-19 booster vaccines are not yet required

A group of industry-leading health experts has concluded that COVID-19 booster vaccines are not yet needed to combat the pandemic. The international team of scientists,...
HPV vaccine

Defence Therapeutics unveil novel HPV vaccine development programme

Industry-leading biotechnology company Defence Therapeutics has revealed that it will be establishing a high priority programme to develop a new HPV vaccine for cervical...
cancer-vaccine

Cancer vaccine developed using Oxford-AstraZeneca vaccine technology

Scientists are utilising the same technology used in the creation of the Oxford-AstraZeneca COVID-19 jab to develop a vaccine to treat cancer. Researchers at the...
Pfizer-BioNTech-vaccine-children

Pfizer-BionNTech vaccine side effects mild to moderate in high-risk children

The side effects of the Pfizer-BionNTech vaccine in clinically vulnerable 12- to 15-year-olds are likely to be minimal, a study has shown. In a small...
delta-variant

COVID-19 vaccines are still effective against Delta variant, study confirms

Two COVID-19 vaccine doses provide the most effective protection from the Delta variant in the UK, a new study has shown. Researchers from the University...
COVID-19-universities

On-site vaccinations and phased return could make universities safer

Offering COVID-19 vaccines on campus and introducing phased returns in the autumn is key to making universities safer, public health experts have said. In an...
drug-delivery-Defence-Therapeutics

Defence Therapeutics selects new variants to optimise drug delivery

Following a thorough evaluation process, Defence Therapeutics has selected the eight most successful variants of its Accum™ drug delivery technology. Biotechnology company Defence Therapeutics continually works...
Bells-palsy-covid-vaccines

COVID-19 vaccine benefits outweigh risk of Bell’s palsy, say researchers

The benefits and efficacy of COVID-19 vaccines far outweigh the minimal risk of developing Bell’s palsy, researchers have said. Following the first large-scale population-based study...
intranasal-vaccine

Pre-clinical trials show intranasal COVID-19 vaccine reduces infection risk

Researchers have made a significant breakthrough in the development of an intranasal COVID-19 vaccine. Scientists from Lancaster University have carried out pre-clinical trials of a...
COVID-19 vaccine effectiveness

COVIDDRIVE: A new initiative to analyse COVID-19 vaccine effectiveness

Europe’s COVID-19 vaccine effectiveness is set to be intrinsically analysed by COVIDRIVE – a new public-private partnership implemented to investigate the medication’s efficacy. The novel...
Defence Therapeutics

Defence Therapeutics: At the forefront of biotech innovation

In this article, we examine the future landscape of the Biotech sector, looking at the companies Defence Therapeutics, MorphoSys, BioNTech, and Pfizer. Infectious diseases are...
double-vaccinated

Double vaccine dose halves COVID-19 infection risk, study estimates

COVID-19 infection rates in England are three times lower in double vaccinated people, the findings from the recent REACT-1 report have revealed. The latest findings...
Defence-Therapeutics

Defence Therapeutics partners with pharmaceutical experts

Biotechnology company Defence Therapeutics has partnered with a pharmaceutical consultancy to maximise the potential of its developments. In a bid to strengthen its development of...

B Medical Systems: Reliable cold chain solutions for every need

Discover more about B Medical Systems’ wide range of solutions available to support the vaccine cold chain, medical refrigeration, and blood management fields. B Medical...
pharmaceutical-industry

The pharmaceutical industry’s response to COVID-19

Nathalie Moll, Director General of the EFPIA, discusses the changes the pharmaceutical industry has implemented to support the healthcare sector through COVID-19. The European Federation...
B-Medical-Systems

B Medical Systems receives environmental backing for refrigeration products

Vaccine cold chain and medical refrigeration specialist B Medical Systems has received Energy Star certification for a range of its products. B Medical Systems’ 115V...
Pfizer-vaccine

Longer interval between Pfizer vaccine doses boosts antibody protection

A longer dosing schedule for the Pfizer COVID-19 vaccine triggered the most effective immune response, new research has found. A new and extensive pre-print study...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest